Stereotaxis, Inc.
STXS- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001289340
No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Stereotaxis, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 61 | 81 | +20 |
| Shares | 37.3M | 40.5M | +3.25M (+8.7%) |
| Value | $65.2M | $105.7M | +$40.5M (+62.2%) |
New holders (25)
Institutions that held Stereotaxis, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (5)
Institutions that held Stereotaxis, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| 683 Capital Management, LLC | 157,719 | $276.0K |
| Boothbay Fund Management, LLC | 34,005 | $59.5K |
| Pacific Global Investment Management CO | 14,650 | $25.6K |
| Barclays PLC | 3,568 | $6.24K |
| Central Trust Co | 1,000 | $1.75K |